Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
<p dir="ltr">Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac. A, B) The top significantly down (A) and up (B) regulated GO pathways in AD-MSC in comparison with PSCs treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM. C, D) T...
Furkejuvvon:
| Váldodahkki: | Sushil Kumar (20371917) (author) |
|---|---|
| Almmustuhtton: |
2025
|
| Fáttát: | |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Supplementary Figure 1: Activation of AD-MSCs and PSCs by Muc5ac
Dahkki: Sushil Kumar (20371917)
Almmustuhtton: (2025) -
Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
Dahkki: Sushil Kumar (20371917)
Almmustuhtton: (2025) -
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
Dahkki: Sushil Kumar (20371917)
Almmustuhtton: (2025) -
Supplementary Figure 6: Age-dependent differences in CAF activation
Dahkki: Sushil Kumar (20371917)
Almmustuhtton: (2025) -
Supplementary Tables
Dahkki: Sushil Kumar (20371917)
Almmustuhtton: (2025)